Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8
Animals
CD8-Positive T-Lymphocytes
/ immunology
Carcinogenesis
Cell Differentiation
Fatty Acids
/ metabolism
Forkhead Transcription Factors
/ genetics
Immune Evasion
Interferon-gamma
/ metabolism
Macrophages
/ immunology
Melanoma
/ immunology
Melanoma, Experimental
Mice
Mice, Inbred C57BL
Mice, Knockout
Neoplasms, Experimental
/ immunology
Neuropilin-1
/ genetics
Sterol Regulatory Element Binding Protein 1
/ metabolism
T-Lymphocytes, Regulatory
/ immunology
Th2 Cells
/ immunology
Tumor Microenvironment
CD8(+) T cell-derived interferon-γ
Treg cells
tumor-promoting macrophages
Journal
Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918
Informations de publication
Date de publication:
20 08 2019
20 08 2019
Historique:
received:
04
05
2018
revised:
19
04
2019
accepted:
20
06
2019
pubmed:
28
7
2019
medline:
18
12
2019
entrez:
28
7
2019
Statut:
ppublish
Résumé
Regulatory T (Treg) cells are crucial for immune homeostasis, but they also contribute to tumor immune evasion by promoting a suppressive tumor microenvironment (TME). Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME. Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types. Treg cells suppressed CD8
Identifiants
pubmed: 31350177
pii: S1074-7613(19)30287-0
doi: 10.1016/j.immuni.2019.06.017
pmc: PMC6703933
mid: NIHMS1535261
pii:
doi:
Substances chimiques
Fatty Acids
0
Forkhead Transcription Factors
0
Foxp3 protein, mouse
0
Sterol Regulatory Element Binding Protein 1
0
Neuropilin-1
144713-63-3
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
381-397.e6Subventions
Organisme : NIAID NIH HHS
ID : R01 AI091977
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NIH HHS
ID : S10 OD019942
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA047904
Pays : United States
Organisme : NIH HHS
ID : S10 OD011925
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA203689
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
J Immunol. 2014 Mar 15;192(6):2904-12
pubmed: 24532574
J Clin Invest. 2015 Sep;125(9):3365-76
pubmed: 26325033
Nature. 2013 Sep 12;501(7466):252-6
pubmed: 23913274
PLoS Comput Biol. 2007 Mar 23;3(3):e39
pubmed: 17381235
Bioinformatics. 2014 May 15;30(10):1473-5
pubmed: 24463181
Cell. 2016 Mar 24;165(1):35-44
pubmed: 26997480
FEBS J. 2016 Jul;283(14):2731-48
pubmed: 26787424
Eur J Immunol. 2014 Dec;44(12):3621-31
pubmed: 25231532
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7817-22
pubmed: 20385828
Nat Immunol. 2014 Sep;15(9):846-55
pubmed: 25086775
Nat Immunol. 2007 Feb;8(2):191-7
pubmed: 17136045
Chem Biol. 2009 Aug 28;16(8):882-92
pubmed: 19716478
Cancer Metab. 2013 Jan 23;1(1):3
pubmed: 24280005
Nat Med. 2016 Dec;22(12):1402-1410
pubmed: 27775706
Cancer Immunol Res. 2016 Sep 2;4(9):721-5
pubmed: 27590281
Cell. 2017 Feb 9;168(4):707-723
pubmed: 28187290
Immunity. 2008 Apr;28(4):546-58
pubmed: 18387831
Immunity. 2016 Feb 16;44(2):316-29
pubmed: 26872697
Cell. 2015 Apr 9;161(2):185-6
pubmed: 26042237
Nat Immunol. 2003 Apr;4(4):330-6
pubmed: 12612578
Bioinformatics. 2015 May 15;31(10):1584-91
pubmed: 25583121
Cancer Cell. 2016 Sep 12;30(3):377-390
pubmed: 27622331
Curr Opin Immunol. 2015 Apr;33:120-5
pubmed: 25728992
Anal Chem. 2011 Apr 15;83(8):3192-8
pubmed: 21428294
Trends Endocrinol Metab. 2012 Feb;23(2):65-72
pubmed: 22154484
Trends Immunol. 2016 Mar;37(3):208-220
pubmed: 26858199
Immunity. 2015 Mar 17;42(3):406-17
pubmed: 25786173
J Exp Med. 2013 Oct 21;210(11):2435-66
pubmed: 24127486
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Trends Mol Med. 2018 May;24(5):472-489
pubmed: 29655673
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51
pubmed: 18042719
Exp Cell Res. 2016 Jan 15;340(2):193-7
pubmed: 26515551
Cancer Res. 2010 Oct 15;70(20):7800-9
pubmed: 20924111
Nat Immunol. 2019 Jun;20(6):724-735
pubmed: 30936494
Immunity. 2015 Jan 20;42(1):18-27
pubmed: 25607456
Cell. 2017 Jun 1;169(6):1130-1141.e11
pubmed: 28552348
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Trends Mol Med. 2016 Jun;22(6):448-451
pubmed: 27174038
Cell. 2016 Sep 8;166(6):1500-1511.e9
pubmed: 27610572
Cell Metab. 2011 Apr 6;13(4):376-388
pubmed: 21459323